How did USNA's Q4 earnings surprise analysts?

**USANA Health Sciences' (USNA) Q4 earnings did not significantly surprise analysts**, as the company's performance was largely in line with expectations. Here are the key details: 1. **Analysts' Expectations**: Before the earnings release, analysts anticipated an earnings per share (EPS) of $0.48 for Q4 2024. 2. **Actual Performance**: USNA reported an EPS of $0.56 for Q4 2024, which beat analysts' expectations. 3. **Revenue and Net Income**: The company's revenue for the quarter was $200.2 million, marking a 6.2% decline from the previous year's Q3. Net income decreased by 6.5%, amounting to $10.6 million. The profit margin remained stable at 5.3%, matching the previous year's Q3 figures. 4. **Market Reaction**: Despite the slight beat on EPS, the market reacted negatively to the news, with the stock hitting a new 52-week low of $34.76 on October 9, 2024. This could indicate broader market concerns or reactions that overshadowed the earnings beat. In conclusion, while USNA's Q4 performance exceeded analysts' expectations in terms of EPS, the overall financial metrics and market conditions suggest that the company faced significant challenges, which may have influenced investor sentiment negatively.